Decreased visible deep medullary veins is a novel imaging marker for cerebral small vessel disease
Authors:
- 18 January 2020
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 41 (6) , 1497-1506
Abstract
Visibility of deep medullary veins (DMVs) seen at SWI is predictive of poor prognosis in ischemic stroke. Few attentions have been paid to DMVs in atherosclerotic cerebral small vessel disease (aCSVD) which is attributed to long-term imbalanced microhemodynamics. We conducted this retrospective study to explore the association between DMVs profiles and aCSVD risk factors, neuroimaging markers.Keywords
Funding Information
- National Natural Science Foundation of China (8167118)
- Guangzhou Science, Technology and Innovation Commission (201704020222)
This publication has 41 references indexed in Scilit:
- Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel diseaseNeurology, 2019
- Serum homocysteine level is related to cerebral small vessel disease in a healthy populationNeurology, 2019
- “Liquid Biopsy” of White Matter Hyperintensity in Functionally Normal EldersFrontiers in Aging Neuroscience, 2018
- Prevalence and Risk Factors of Cerebral Small Vessel Disease in a Chinese Population-Based SampleJournal of Stroke, 2018
- Compromised Blood–Brain Barrier Integrity Is Associated With Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel DiseaseFrontiers in Neurology, 2018
- Blood–brain barrier leakage is more widespread in patients with cerebral small vessel diseaseNeurology, 2017
- Inflammatory biomarkers, cerebral microbleeds, and small vessel diseaseNeurology, 2015
- Ambulatory Blood Pressure in Patients With Lacunar StrokeStroke, 2013
- Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR studyAtherosclerosis, 2011
- Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challengesThe Lancet Neurology, 2010